Payer PolicyActive
SURG.00088 Coblation® Therapies for Musculoskeletal Conditions
ANTHEM-SURG.00088
Anthem
Effective: October 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses the use of Coblation (cold ablation, bipolar radiofrequency) devices for musculoskeletal procedures, including arthroscopic soft-tissue debridement, tendon debridement, meniscal sculpting/removal, and subacromial decompression. Anthem deems Coblation technology investigational and not medically necessary for all musculoskeletal indications; therefore, it is not covered. No indications are covered; related services may be billed under unlisted procedure codes 20999 or 29999.
Coverage Criteria Preview
Key requirements from the full policy
"The use of Coblation technology is consideredinvestigational and not medically necessaryfor the treatment of musculoskeletal conditions."
Sign up to see full coverage criteria, indications, and limitations.